Is M&A The Survival Strategy For Korean Companies? KPMA President Lee Kyeong-Ho Thinks So
This article was originally published in PharmAsia News
Executive Summary
Lee Kyeong-Ho, president of the Korea Pharmaceutical Manufacturers Association, expects that local Korean companies will have to pursue M&A to survive a harsh business environment.
You may also be interested in...
Korean Government Launches Strongest-ever Drive To Root Out Rebates
SEOUL - In the strongest ever all-out government crackdown on rebates between hospital doctors and pharmaceutical companies, the Korean government established a joint task force at a Seoul Prosecution Office that it hopes will add teeth to better enforce anti-rebate laws implemented last November
South Korean Pharmas Clamber For Partnerships To Survive Rapidly Changing Environment
SEOUL - South Korea's local pharmas are clambering to tie the knot with multinationals and among themselves in what appears to be a "marriage of necessity" in a desperate attempt to survive a government crackdown on rebates, on which locals have long depended
Early-Stage Idiopathic Pulmonary Fibrosis (IPF) Candidates Race to Phase III
Multiple IPF drugs are being rushed into Phase III based on early-stage signals of efficacy and safety presented at the ATS meeting. Scrip spoke with the University of Pittsburgh's Kevin Gibson about the candidates, trial design, combination therapy and limitations of current therapy.